LinqMed Inc.
PrivateLast Round
Series B
Extension
May 12, 2025
Total Funding Raised
$39.55M
Company Overview
LinqMed Inc. is a radiopharmaceutical company developing a drug discovery platform and innovative 'visible' anti-cancer treatments using the copper radioisotope 64Cu.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LinqMed Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
LinqMed Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 12, 2025 | ||||
| Series B Extension | Apr 9, 2025 | ||||
| Series B | Jan 10, 2025 | ||||
| Series A | Dec 22, 2023 | ||||
| Grant | Dec 22, 2023 |
LinqMed Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series B Extension |
| Keio Innovation Initiative | Series B Extension |
| Mizuho Capital | Series A |
| New Energy and Industrial Technology Development Organization | Grant |
| Chibagin Capital | Series B Extension |
| Bio-Sight Capital | Series A, Series B Extension |
| Nissay Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
$2M round with Nissay Capital participating.
- Apr 9, 2025
$14.47M round with Sumitomo Mitsui Trust Bank and Chibagin Capital.
LinqMed Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LinqMed Inc.'s valuation, stock price, and market status.